About the Company

Amgen Inc. is a leading global biotechnology company headquartered in Thousand Oaks, California, discovering, developing, and delivering innovative human therapeutics serving millions worldwide with $28B+ annual revenue through breakthrough medicines like Prolia, Repatha, and Enbrel targeting oncology, cardiovascular, and inflammation diseases. Pioneering biosimilars expansion, AI-driven drug discovery, and precision medicine alongside strategic gene therapy investments, Amgen drives healthcare innovation through major India technology center in Hyderabad building mission-critical clinical trial platforms and data analytics infrastructure globally.